| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | ARM-type_fold | MON2 SAAL1 APC2 ARMC2 RYR3 KPNA7 XPO6 PKP2 ULK4 GCN1 NIPBL HEATR4 DOCK9 UBR4 APOB MEI1 PPP2R1B RIF1 PKP3 WDFY3 IPO11 | 1.56e-10 | 339 | 204 | 21 | IPR016024 |
| Domain | - | MON2 SAAL1 APC2 ARMC2 KPNA7 XPO6 PKP2 ULK4 GCN1 NIPBL HEATR4 PPP2R1B RIF1 PKP3 WDFY3 IPO11 | 3.03e-09 | 222 | 204 | 16 | 1.25.10.10 |
| Domain | ARM-like | MON2 SAAL1 APC2 ARMC2 KPNA7 XPO6 PKP2 ULK4 GCN1 NIPBL HEATR4 MEI1 PPP2R1B RIF1 PKP3 WDFY3 IPO11 | 7.39e-09 | 270 | 204 | 17 | IPR011989 |
| Domain | ARM | 4.44e-06 | 40 | 204 | 6 | SM00185 | |
| Domain | Armadillo | 1.17e-05 | 47 | 204 | 6 | IPR000225 | |
| Domain | ARM_REPEAT | 7.14e-05 | 40 | 204 | 5 | PS50176 | |
| Domain | HEAT_REPEAT | 1.16e-04 | 70 | 204 | 6 | PS50077 | |
| Pubmed | EFCAB5 EFTUD2 FAM186A PRPF19 HSP90AB1 DNHD1 CAD NSD1 TEX15 TERT SNX25 MDC1 NAT10 CDC5L PC | 1.75e-11 | 234 | 211 | 15 | 36243803 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | SRCAP EFTUD2 GCN1 NIPBL HSP90AB1 WASHC2C UBR4 SMC4 RNF213 NUP214 RIF1 PHF3 ATF7IP MDC1 NAT10 MORC3 AHNAK2 | 2.68e-11 | 332 | 211 | 17 | 32786267 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KDM3A ZNF318 EFTUD2 SLC41A3 XPO6 AFDN CDT1 NIPBL HSP90AB1 FOXM1 WASHC2C GTSE1 MYO18A NUP214 USP10 RIF1 SETD2 PHF3 PKP3 MDC1 ASPH APPL1 COASY SON | 7.70e-11 | 774 | 211 | 24 | 15302935 |
| Pubmed | NES APC2 ZNF318 PPM1H EFTUD2 ZNF394 AFDN MGA CAMSAP2 NIPBL HSP90AB1 CAD NYAP2 DSCAM UBR4 NSD1 SRGAP2 ARPC4 USP10 CELSR2 ATF7IP NAT10 DZIP3 APPL1 WDFY3 CDC5L | 2.36e-10 | 963 | 211 | 26 | 28671696 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZNF318 SRCAP DDX10 EFTUD2 PRPF19 CAMSAP2 GCN1 NIPBL HSP90AB1 WASHC2C SRGAP2 NUP214 SNX29 USP10 RIF1 SETD2 ATF7IP NAT10 NCOA7 CDC5L PC CPSF3 EPB41 SON AHNAK2 | 6.42e-10 | 934 | 211 | 25 | 33916271 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NES RPN1 SRCAP DDX10 EFTUD2 MCM3AP PKP2 PRPF19 AFDN MGA GCN1 NIPBL HSP90AB1 CAD FN1 UBR4 SMC4 NUP214 ARPC4 RIF1 METTL13 MDC1 NAT10 ASPH CSTA WDFY3 CDC5L CPSF3 SON AHNAK2 | 9.61e-10 | 1353 | 211 | 30 | 29467282 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RPN1 ZNF318 DDX10 EFTUD2 PRPF19 AFDN MGA NIPBL HSP90AB1 GTSE1 NVL NSD1 ZDBF2 NUP214 RSBN1 RIF1 SETD2 PHF3 ATF7IP MDC1 NAT10 CDC5L PC EPB41 SON | 9.89e-10 | 954 | 211 | 25 | 36373674 |
| Pubmed | NES ZNF318 DDX10 MCM3AP AFDN GCN1 NIPBL CAD FN1 UBR4 SMC4 NVL NSD1 NUP214 RIF1 PHF3 MDC1 NAT10 CPSF3 SON | 3.92e-09 | 653 | 211 | 20 | 22586326 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 SREBF1 SRCAP PLEKHM1 PLEKHH3 PPP1R26 TBC1D16 STX4 XPO6 MCM3AP ULK4 GCN1 CREB3 PLOD3 DOCK9 UBR4 GTSE1 NSD1 SRGAP2 NUP214 CELSR2 WDFY3 MAPKBP1 ZNF839 PC AHNAK2 | 4.19e-09 | 1105 | 211 | 26 | 35748872 |
| Pubmed | KDM3A RPN1 ZNF318 SRCAP AFDN MGA GCN1 CAD SMC4 NSD1 USP10 SETD2 PHF3 MDC1 NAT10 CDC5L PC EPB41 | 8.61e-09 | 549 | 211 | 18 | 38280479 | |
| Pubmed | CDCA3 MCAM ZNF318 EFTUD2 NEO1 PKP2 AFDN MGA GCN1 FN1 EFCAB6 DSCAM RNF213 APOB ANKRD50 DNAH7 RIF1 ATF7IP PC EPB41 STOM | 1.39e-08 | 777 | 211 | 21 | 35844135 | |
| Pubmed | RPN1 EFTUD2 PRPF19 MGA GCN1 NIPBL HSP90AB1 CAD UBR4 ZDBF2 RIF1 PKP3 NAT10 | 1.41e-08 | 272 | 211 | 13 | 31010829 | |
| Pubmed | MON2 CDCA3 URI1 SAAL1 MCAM PPM1H PIK3R1 NHS PRPF19 GCN1 HSP90AB1 EFL1 CAD PLOD3 KIAA1549 RNF213 IDE ARHGAP5 RIF1 NAT10 CRYBG3 CDC5L PC CPSF3 | 2.94e-08 | 1049 | 211 | 24 | 27880917 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | NES MCAM ZNF318 GCN1 GTSE1 SMC4 ZDBF2 NUP214 DENND4C USP10 EPB41 AHNAK2 | 6.34e-08 | 256 | 211 | 12 | 33397691 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NES CHEK1 PPM1H FSIP2 PKP2 NHS AFDN CAMSAP2 GTSE1 BRSK2 SRGAP2 DNAH7 DENND4C PHF3 NCOA7 CRYBG3 MORC3 PC MUSK EPB41 AHNAK2 | 7.89e-08 | 861 | 211 | 21 | 36931259 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RPN1 DDX10 EFTUD2 PKP2 PRPF19 HSP90AB1 CAD GTSE1 MYO18A SMC4 APOB ARPC4 USP10 METTL13 PKP3 MDC1 NAT10 CDC5L PC CPSF3 EPB41 SON | 9.18e-08 | 949 | 211 | 22 | 36574265 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CHEK1 EFTUD2 XPO6 PRPF19 GCN1 NIPBL HSP90AB1 SMC4 GTPBP1 USP10 PPP2R1B RIF1 METTL13 PKP3 NAT10 CDC5L CPSF3 | 1.19e-07 | 582 | 211 | 17 | 20467437 |
| Pubmed | MON2 RPN1 NEO1 SCN1A AFDN CAMSAP2 GCN1 HSP90AB1 CAD NYAP2 WASHC2C DOCK9 UBR4 BRSK2 MYO18A ZDBF2 YARS1 CELSR2 SNX25 APPL1 CRYBG3 PC EPB41 GABBR1 | 1.35e-07 | 1139 | 211 | 24 | 36417873 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPN1 DDX10 EFTUD2 PRPF19 AFDN GCN1 NIPBL HSP90AB1 DNHD1 CAD UBR4 SMC4 APOB NUP214 IDE GTPBP1 YARS1 USP10 RIF1 METTL13 MDC1 NAT10 CSTA COASY CDC5L PC CPSF3 | 1.76e-07 | 1425 | 211 | 27 | 30948266 |
| Pubmed | MON2 SAAL1 RPN1 XPO6 GCN1 COG4 HSP90AB1 RNF213 PPP2R1B IPO11 | 1.98e-07 | 183 | 211 | 10 | 23956138 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NES ZNF318 SRCAP DDX10 EFTUD2 STX4 PRPF19 AFDN MGA GCN1 NIPBL HSP90AB1 CAD GTSE1 SMC4 NUP214 RIF1 PKP3 MDC1 NAT10 CDC5L SON | 3.35e-07 | 1024 | 211 | 22 | 24711643 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | MON2 A2M MCAM SRCAP EFTUD2 SLC41A3 VILL NHS MGA FN1 DOCK9 SMC4 SRGAP2 | 3.98e-07 | 363 | 211 | 13 | 14691545 |
| Pubmed | RPN1 EFTUD2 PRPF19 GCN1 HSP90AB1 CAD UBR4 SMC4 NUP214 USP10 RIF1 NAT10 APPL1 CDC5L CPSF3 IPO11 SON | 4.30e-07 | 638 | 211 | 17 | 33239621 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RPN1 DDX10 EFTUD2 PRPF19 GCN1 NIPBL HSP90AB1 CAD UBR4 SMC4 NUP214 GTPBP1 TERT ARPC4 YARS1 RSBN1 METTL13 NAT10 MORC3 CDC5L PC CPSF3 STOM IPO11 SON | 5.14e-07 | 1318 | 211 | 25 | 30463901 |
| Pubmed | CHEK1 PIK3R1 PKP2 PRPF19 AFDN HSP90AB1 CAD SRGAP2 CDC5L CPSF3 SON | 5.18e-07 | 255 | 211 | 11 | 15324660 | |
| Pubmed | A2M RPN1 GC EFTUD2 PRPF19 NIPBL HSP90AB1 FN1 SMC4 APOB RIF1 MDC1 NAT10 CSTA CDC5L STOM SON | 5.79e-07 | 652 | 211 | 17 | 31180492 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | KDM3A MCAM ZNF318 MGA HSP90AB1 FOXM1 WASHC2C GTSE1 USP10 PHF3 CSTA CDC5L PC AHNAK2 | 6.51e-07 | 444 | 211 | 14 | 34795231 |
| Pubmed | A2M PRSS8 USP25 MCAM PPP1R26 MCM3AP PKP2 AFDN MGA FLT4 FN1 UBR4 SMURF1 ARHGAP5 ATF7IP SON | 7.71e-07 | 591 | 211 | 16 | 15231748 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 1.12e-06 | 221 | 211 | 10 | 29991511 | |
| Pubmed | KDM3A ZNF318 DDX10 EFTUD2 PRPF19 MGA FOXM1 GTSE1 NVL ZDBF2 NAT10 CDC5L | 1.27e-06 | 339 | 211 | 12 | 30415952 | |
| Pubmed | 1.32e-06 | 225 | 211 | 10 | 12168954 | ||
| Pubmed | MON2 MCM3AP CAMSAP2 WASHC2C DOCK9 SMURF1 NUP214 RSBN1 PHF3 ITSN2 DZIP3 MAPKBP1 SON | 1.43e-06 | 407 | 211 | 13 | 12693553 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | URI1 RPN1 EFTUD2 PRPF19 GCN1 NIPBL HSP90AB1 CAD PLOD3 UBR4 SMC4 SRGAP2 ARPC4 YARS1 USP10 RIF1 PKP3 MDC1 ASPH CTH COASY CDC5L PC SON AHNAK2 | 1.85e-06 | 1415 | 211 | 25 | 28515276 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | MON2 MAK URI1 SAAL1 CHEK1 SLC7A11 PPM1H EFTUD2 CEP120 XPO6 PIK3R1 AFDN CAMSAP2 GCN1 SMC4 SRGAP2 ARPC4 DENND4C RIF1 DZIP3 APPL1 MORC3 STOM IPO11 | 1.87e-06 | 1321 | 211 | 24 | 27173435 |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | ZNF318 EFTUD2 MGA GCN1 HSP90AB1 CAD NVL NUP214 ATF7IP MDC1 CSTA PC | 2.17e-06 | 357 | 211 | 12 | 37059091 |
| Pubmed | CHMP7 NHS AFDN NIPBL HSP90AB1 CAD WASHC2C GTSE1 DENND4C USP10 RIF1 PHF3 PKP3 SON | 2.80e-06 | 503 | 211 | 14 | 16964243 | |
| Pubmed | MON2 NES NEO1 CDT1 MGA COG4 NVL RNF213 ZDBF2 SRGAP2 NUP214 DENND4C SETD2 PHF3 MDC1 CDC5L CPSF3 | 2.82e-06 | 733 | 211 | 17 | 34672954 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | RPN1 KRT73 EFTUD2 PRPF19 MGA HSP90AB1 CAD NVL ZDBF2 GTPBP1 RIF1 PHF3 CDC5L EPB41 SON | 3.20e-06 | 583 | 211 | 15 | 29844126 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | A2M NES SAAL1 AKR1A1 EFTUD2 CHMP7 AFDN GCN1 HSP90AB1 UBR4 MYO18A SMC4 RNF213 NUP214 IDE GTPBP1 ARPC4 PPP2R1B PC CPSF3 EPB41 IPO11 SON AHNAK2 | 3.35e-06 | 1367 | 211 | 24 | 32687490 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ZNF318 SRCAP PKP2 CAD PLOD3 NVL NUP214 USP10 PPP2R1B SETD2 PHF3 MDC1 NAT10 | 3.36e-06 | 440 | 211 | 13 | 34244565 |
| Pubmed | A2M RPN1 DDX10 MCM3AP PKP2 PRPF19 CCDC106 GCN1 HSP90AB1 FN1 APOB GTPBP1 RSBN1 ARHGAP5 USP10 RIF1 METTL13 PHF3 NAT10 ASPH CSTA PC STOM SON | 3.52e-06 | 1371 | 211 | 24 | 36244648 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MON2 TBC1D2B ZNF318 SRCAP MCM3AP FOXM1 CAD WASHC2C HIPK2 ZDBF2 YARS1 SETD2 ATF7IP CRYBG3 MORC3 | 3.55e-06 | 588 | 211 | 15 | 38580884 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MON2 SAAL1 USP25 ZNF318 DDX10 CEP68 PKP2 GCN1 PLOD3 GTSE1 MYO18A NVL NUP214 IDE CPSF3 STOM IPO11 | 4.11e-06 | 754 | 211 | 17 | 33060197 |
| Pubmed | MON2 ABCA12 EMILIN3 CLSTN2 ZNF318 CHEK1 SRCAP PIK3R1 MCM3AP PKP2 MGA KIAA1549 RNF213 SLC4A1 RSBN1 SETD2 METTL13 NAT10 WDFY3 CRYBG3 SON | 5.02e-06 | 1116 | 211 | 21 | 31753913 | |
| Pubmed | 6.51e-06 | 160 | 211 | 8 | 31678930 | ||
| Pubmed | CDCA3 NES SAMD9 KRT73 PLOD3 GTSE1 ANKRD50 RSBN1 RIF1 PHF3 CSTA CRYBG3 EPB41 | 7.15e-06 | 472 | 211 | 13 | 38943005 | |
| Pubmed | MON2 SAAL1 RPN1 EFTUD2 STX4 PRPF19 GCN1 COG4 CAD PLOD3 UBR4 GTSE1 SMC4 RNF213 ARPC4 USP10 PPP2R1B MDC1 NAT10 ASPH CSTA CDC5L IPO11 AHNAK2 | 8.02e-06 | 1440 | 211 | 24 | 30833792 | |
| Pubmed | RPN1 PRPF19 AFDN GCN1 HSP90AB1 FN1 UBR4 MYO18A GTPBP1 YARS1 USP10 PKP3 NAT10 ASPH COASY STOM | 8.13e-06 | 711 | 211 | 16 | 33022573 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | A2M SAMD9 RPN1 EFTUD2 PKP2 PRPF19 HSP90AB1 CAD PLOD3 MYO18A SMC4 GTPBP1 ARPC4 YARS1 USP10 PHF3 PKP3 MDC1 NAT10 ASPH CSTA CDC5L | 9.25e-06 | 1257 | 211 | 22 | 36526897 |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 9.31e-06 | 168 | 211 | 8 | 30631154 | |
| Pubmed | PIK3R1 MCM3AP MGA GCN1 COG4 HSP90AB1 MYO18A HIPK2 NUP214 RIF1 ATF7IP ITSN2 ZNF839 | 9.75e-06 | 486 | 211 | 13 | 20936779 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | RPN1 EFTUD2 PIK3R1 PRPF19 CAD SMC4 GTPBP1 USP10 METTL13 NAT10 ASPH CDC5L PC | 9.75e-06 | 486 | 211 | 13 | 30940648 |
| Pubmed | 9.78e-06 | 223 | 211 | 9 | 33731348 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | CDCA3 STX4 PKP2 NHS AFDN GCN1 HSP90AB1 DOCK9 SRGAP2 NUP214 DENND4C ARHGAP5 PKP3 EPB41 | 1.05e-05 | 565 | 211 | 14 | 25468996 |
| Pubmed | SAAL1 ZNF318 SRCAP VILL PIK3R1 MGA COG4 TMEM248 WASHC2C FN1 DOCK9 SMURF1 NSD1 HIPK2 APOB SRGAP2 ANKRD50 ARHGAP5 NAT10 DZIP3 | 1.13e-05 | 1084 | 211 | 20 | 11544199 | |
| Pubmed | KDM3A APC2 USP25 RYR3 PIK3R1 AFDN NIPBL COG4 HSP90AB1 FN1 DSCAM UBR4 SRGAP2 YARS1 RBCK1 ARHGAP5 NSMF TMEM168 APPL1 WDFY3 MORC3 PC | 1.30e-05 | 1285 | 211 | 22 | 35914814 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | URI1 ARMC2 PLEKHM1 PPM1H TMCO4 SLC41A3 SMURF1 HIPK2 RNF213 SRGAP2 IDE CERT1 SNX29 USP10 PPP2R1B PPARGC1B PKP3 NAT10 ASPH WDR45B PNPLA7 ZNF839 PEA15 EPB41 | 1.39e-05 | 1489 | 211 | 24 | 28611215 |
| Pubmed | NES EFTUD2 PRPF19 CAD PLOD3 MYO18A NVL SRGAP2 NUP214 ARPC4 USP10 MDC1 NAT10 CDC5L CPSF3 | 1.40e-05 | 660 | 211 | 15 | 32780723 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RPN1 SREBF1 ZNF318 SRCAP EFTUD2 PRPF19 MGA NIPBL NSD1 NUP214 RIF1 SETD2 PHF3 PKP3 MDC1 NAT10 ASPH CDC5L PC CPSF3 STOM SON | 1.45e-05 | 1294 | 211 | 22 | 30804502 |
| Pubmed | URI1 RPN1 SRCAP EFTUD2 PRPF19 HSP90AB1 UBR4 ASPH CDC5L IPO11 | 1.66e-05 | 300 | 211 | 10 | 28561026 | |
| Pubmed | A2M SREBF1 ODR4 ULK4 MGA FOXM1 CAD MYO18A SMC4 APOB NUP214 YARS1 SETD2 MDC1 NAT10 GRIP2 | 1.67e-05 | 754 | 211 | 16 | 35906200 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RPN1 TRAIP DDX10 PRPF19 GCN1 MYO18A NVL GTPBP1 RSBN1 USP10 RIF1 PHF3 NAT10 ASPH CDC5L SON | 1.81e-05 | 759 | 211 | 16 | 35915203 |
| Pubmed | RPN1 EFTUD2 PRPF19 WASHC2C SMC4 NVL ARPC4 ARHGAP5 USP10 RIF1 PHF3 MDC1 NAT10 ASPH CDC5L CPSF3 SON | 1.85e-05 | 847 | 211 | 17 | 35850772 | |
| Pubmed | 2.32e-05 | 312 | 211 | 10 | 37120454 | ||
| Pubmed | 2.42e-05 | 250 | 211 | 9 | 33536335 | ||
| Pubmed | EFCAB5 RPN1 ZNF318 SRCAP KRT73 C9orf43 FAM186A PRPF19 DLEC1 CAMSAP2 NIPBL HSP90AB1 UBR4 MYO18A SMC4 APOB ARPC4 CCDC148 SNX25 AVIL PAEP ITSN2 IL1R1 | 2.50e-05 | 1442 | 211 | 23 | 35575683 | |
| Pubmed | KDM3A URI1 SAAL1 XPO6 CAMSAP2 NVL NUP214 IDE GTPBP1 RSBN1 CPSF3 EPB41 IPO11 | 2.56e-05 | 533 | 211 | 13 | 25544563 | |
| Pubmed | EFTUD2 ODR4 PRPF19 MGA HSP90AB1 CAD UBR4 SMC4 YARS1 USP10 RIF1 NAT10 CDC5L | 3.61e-05 | 551 | 211 | 13 | 34728620 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 34859814 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 1639060 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 28319067 | ||
| Pubmed | Cell cycle G2/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R. | 3.66e-05 | 2 | 211 | 2 | 20609246 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 22119253 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 16332694 | ||
| Pubmed | CoA synthase is in complex with p85alphaPI3K and affects PI3K signaling pathway. | 3.66e-05 | 2 | 211 | 2 | 19482007 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 38581027 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 28347241 | ||
| Pubmed | Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation. | 3.66e-05 | 2 | 211 | 2 | 18157086 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 30075819 | ||
| Pubmed | The AAA-ATPase NVL2 is a telomerase component essential for holoenzyme assembly. | 3.66e-05 | 2 | 211 | 2 | 22226966 | |
| Pubmed | MicroRNA‑378d inhibits Glut4 by targeting Rsbn1 in vitamin D deficient ovarian granulosa cells. | 3.66e-05 | 2 | 211 | 2 | 33760197 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 28754676 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 21285318 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 31060750 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 39190359 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 24131248 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 12752570 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 23074218 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 18022635 | ||
| Pubmed | Prp19 Arrests Cell Cycle via Cdc5L in Hepatocellular Carcinoma Cells. | 3.66e-05 | 2 | 211 | 2 | 28387715 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 29518389 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 9988280 | ||
| Pubmed | Stomatin modulates the activity of the Anion Exchanger 1 (AE1, SLC4A1). | 3.66e-05 | 2 | 211 | 2 | 28387307 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 37898396 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 38136609 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 9360994 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 30231795 | ||
| Pubmed | NES RPN1 PIK3R1 PKP2 MGA GCN1 DOCK9 SMC4 SRGAP2 NUP214 ARHGAP5 RIF1 ITSN2 CSTA APPL1 CPSF3 STOM | 4.91e-05 | 916 | 211 | 17 | 32203420 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 4.91e-05 | 341 | 211 | 10 | 32971831 | |
| Pubmed | 4.94e-05 | 274 | 211 | 9 | 34244482 | ||
| Interaction | NUP43 interactions | KDM3A CLSTN2 ZNF318 AKR1A1 SRCAP FSIP2 MCM3AP MGA NIPBL HSP90AB1 DSCAM NSD1 ZDBF2 NUP214 RSBN1 RIF1 SETD2 ATF7IP MDC1 FAM199X SON AHNAK2 | 7.34e-07 | 625 | 211 | 22 | int:NUP43 |
| Interaction | CDC25B interactions | CHEK1 PPM1H AFDN CAMSAP2 FOXM1 BRSK2 SMC4 SRGAP2 DENND4C CDC5L | 1.51e-06 | 134 | 211 | 10 | int:CDC25B |
| Interaction | TOP3B interactions | MON2 SREBF1 SRCAP PLEKHM1 PLEKHH3 PPP1R26 TBC1D16 ZNF250 STX4 XPO6 MCM3AP PKP2 ULK4 GCN1 CREB3 CAD PLOD3 DOCK9 UBR4 GTSE1 NSD1 APOB SRGAP2 NUP214 GTPBP1 ARPC4 YARS1 USP10 CELSR2 MDC1 WDFY3 MAPKBP1 ZNF839 PC AHNAK2 | 3.96e-06 | 1470 | 211 | 35 | int:TOP3B |
| Interaction | SUMO2 interactions | USP25 SRCAP EFTUD2 GCN1 NIPBL HSP90AB1 CAD WASHC2C UBR4 SMC4 HIPK2 RNF213 NUP214 RIF1 PHF3 ATF7IP MDC1 NAT10 MORC3 AHNAK2 | 4.35e-06 | 591 | 211 | 20 | int:SUMO2 |
| Interaction | PML interactions | KDM3A MCAM ZNF318 PKP2 GCN1 HSP90AB1 FOXM1 PLOD3 WASHC2C GTSE1 HIPK2 RNF213 TERT RBCK1 USP10 PHF3 ATF7IP PKP3 MDC1 NAT10 CSTA WDR45B MORC3 CDC5L PC AHNAK2 | 5.40e-06 | 933 | 211 | 26 | int:PML |
| Interaction | AR interactions | KDM3A SREBF1 ZNF318 SRCAP EFTUD2 PIK3R1 PRPF19 MGA GCN1 NIPBL HSP90AB1 FN1 EFCAB6 MYO18A NVL NSD1 HIPK2 RNF213 IDE USP10 METTL13 PHF3 MDC1 APPL1 MORC3 CDC5L SON | 5.40e-06 | 992 | 211 | 27 | int:AR |
| Interaction | TESK2 interactions | 8.22e-06 | 97 | 211 | 8 | int:TESK2 | |
| Interaction | MAU2 interactions | 1.35e-05 | 136 | 211 | 9 | int:MAU2 | |
| Interaction | GPR45 interactions | MON2 SAAL1 PLEKHH3 MCM3AP GCN1 COG4 RNF213 PPP2R1B RIF1 METTL13 WDFY3 STOM IPO11 | 1.77e-05 | 300 | 211 | 13 | int:GPR45 |
| Interaction | NAA40 interactions | ZNF318 SRCAP DDX10 EFTUD2 PRPF19 CAMSAP2 GCN1 NIPBL HSP90AB1 WASHC2C SRGAP2 NUP214 SNX29 USP10 RIF1 SETD2 ATF7IP NAT10 NCOA7 CDC5L PC CPSF3 EPB41 SON AHNAK2 | 3.52e-05 | 978 | 211 | 25 | int:NAA40 |
| Interaction | SMC5 interactions | RPN1 ZNF318 DDX10 EFTUD2 PRPF19 AFDN MGA NIPBL HSP90AB1 GTSE1 NVL NSD1 ZDBF2 NUP214 RSBN1 RIF1 SETD2 PHF3 ATF7IP MDC1 NAT10 CDC5L PC EPB41 SON | 5.05e-05 | 1000 | 211 | 25 | int:SMC5 |
| Interaction | RICTOR interactions | RPN1 MCAM PLEKHM1 ZNF250 STX4 AFDN MGA GCN1 HSP90AB1 CAD WASHC2C MYO18A SMC4 NUP214 AVIL ASPH CSTA CDC5L PC EPB41 AHNAK2 | 5.08e-05 | 759 | 211 | 21 | int:RICTOR |
| Interaction | TRIM66 interactions | MON2 ZNF318 PIK3R1 MCM3AP PKP2 RNF213 SETD2 METTL13 WDFY3 CRYBG3 | 6.29e-05 | 205 | 211 | 10 | int:TRIM66 |
| Interaction | SCN2B interactions | 6.33e-05 | 95 | 211 | 7 | int:SCN2B | |
| Interaction | NPY2R interactions | 6.61e-05 | 66 | 211 | 6 | int:NPY2R | |
| Interaction | RHOB interactions | CDCA3 RPN1 TBC1D2B MCAM CHEK1 SLC7A11 NEO1 STX4 PIK3R1 PKP2 AFDN DOCK9 BRSK2 MYO18A SMURF1 KIAA1549 SNX29 ARHGAP5 NCOA7 APPL1 COASY STOM | 7.51e-05 | 840 | 211 | 22 | int:RHOB |
| Interaction | DENND1A interactions | 9.34e-05 | 101 | 211 | 7 | int:DENND1A | |
| Cytoband | 12q14.1 | 2.88e-04 | 28 | 211 | 3 | 12q14.1 | |
| Cytoband | 3q26.1 | 2.88e-04 | 28 | 211 | 3 | 3q26.1 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.84e-05 | 43 | 138 | 5 | 409 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.31e-05 | 161 | 138 | 8 | 593 | |
| GeneFamily | Immunoglobulin like domain containing | 1.19e-04 | 193 | 138 | 8 | 594 | |
| GeneFamily | Fibronectin type III domain containing | 2.29e-04 | 160 | 138 | 7 | 555 | |
| GeneFamily | Myb/SANT domain containing|NineTeen complex | 1.18e-03 | 7 | 138 | 2 | 1361 | |
| GeneFamily | Gelsolin/villins | 1.57e-03 | 8 | 138 | 2 | 950 | |
| Coexpression | GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_DN | TBC1D2B AKR1A1 PRPF19 SRGAP2 BTN3A1 YARS1 RBCK1 IER2 COASY STOM | 5.26e-06 | 199 | 211 | 10 | M7645 |
| Coexpression | GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP | 1.08e-05 | 171 | 211 | 9 | M2947 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | WSB1 KDM3A SLC7A11 PLEKHM1 ZNF394 NIPBL HSP90AB1 WASHC2C SMURF1 ADAMTS5 BTN3A1 DENND4C SETD2 PHF3 ATF7IP ITSN2 CTH WDFY3 MORC3 AHNAK2 | 1.21e-05 | 822 | 211 | 20 | M6782 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | SAAL1 SAMD9 CHEK1 SLC7A11 NIPBL FOXM1 EFL1 FN1 SMURF1 SMC4 SRGAP2 YARS1 ARHGAP5 USP10 RIF1 CDC5L CPSF3 AHNAK2 | 2.39e-05 | 721 | 211 | 18 | M10237 |
| Coexpression | GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 3.19e-05 | 196 | 211 | 9 | M4244 | |
| Coexpression | WHITFIELD_CELL_CYCLE_G2_M | 3.46e-05 | 198 | 211 | 9 | M2077 | |
| Coexpression | GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | URI1 TBC1D2B TBC1D16 SLC41A3 IL27RA MYO18A RNF213 ATF7IP IL1R1 | 3.74e-05 | 200 | 211 | 9 | M302 |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_DN | 3.74e-05 | 200 | 211 | 9 | M4569 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN | 3.74e-05 | 200 | 211 | 9 | M5225 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_1_DN | NES PRSS8 TRAIP MCAM CDT1 GCN1 GTSE1 SMURF1 SRGAP2 IER2 ITSN2 PEA15 | 6.16e-05 | 378 | 211 | 12 | M17788 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_UP | WSB1 KDM3A APC2 PLEKHM1 ZNF250 ZNF394 ODR4 GTPBP1 ATF7IP CTH MORC3 PEA15 STOM | 7.09e-05 | 445 | 211 | 13 | M7928 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | CDCA3 NES TRAIP CHEK1 CDT1 FOXM1 FN1 GTSE1 SMC4 SRGAP2 RIF1 PPARGC1B SNX25 MDC1 ASPH | 7.55e-05 | 578 | 211 | 15 | M2368 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.68e-09 | 169 | 211 | 10 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.10e-08 | 199 | 211 | 10 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.30e-08 | 200 | 211 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.89e-07 | 194 | 211 | 9 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.42e-07 | 197 | 211 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-06 | 184 | 211 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-06 | 184 | 211 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-06 | 184 | 211 | 8 | 8260e688ec42a1374727bc85dceb7edd19a8b662 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-06 | 184 | 211 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo|lymph-node_spleen / Manually curated celltypes from each tissue | 3.58e-06 | 190 | 211 | 8 | 4225bfa10a6fb909a3ba8ac26f3541c390b46737 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.02e-06 | 193 | 211 | 8 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.02e-06 | 193 | 211 | 8 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.18e-06 | 194 | 211 | 8 | 8f313071933451780309d2174ed27d8cdc734343 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.68e-06 | 197 | 211 | 8 | 1d4ccca2ff46fccb3ac052b5148cb7f94231d65a | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.68e-06 | 197 | 211 | 8 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.85e-06 | 198 | 211 | 8 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | Caecum-T_cell-cycling_gd_T|Caecum / Region, Cell class and subclass | 4.85e-06 | 198 | 211 | 8 | 5b719b67f8384863077070e1eb7e04a320e6dab4 | |
| ToppCell | Caecum-(1)_T_cell-(18)_cycling_gd_T|Caecum / shred on region, Cell_type, and subtype | 4.85e-06 | 198 | 211 | 8 | 64278d8831c81874937e76b561c53928dfc437c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.23e-06 | 200 | 211 | 8 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 5.23e-06 | 200 | 211 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-06 | 150 | 211 | 7 | 47ea08d7609e1d2382bf56ef9e5c767e3597cf93 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.95e-06 | 154 | 211 | 7 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.95e-06 | 154 | 211 | 7 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | CD8+_Memory_T_cell-RSV-6|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.06e-05 | 158 | 211 | 7 | 5ae737757a49fc96bde1e57e02066f9f65654ea1 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-05 | 162 | 211 | 7 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 165 | 211 | 7 | e2aebb2fe197151e019371b8960f76f0c2386f08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 165 | 211 | 7 | b087771499aeb31cc4a338d2d0a9392a4ec1ac45 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 165 | 211 | 7 | d8f8b088fd28a6b9dbd6b51bcaee42000e963321 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-05 | 166 | 211 | 7 | b64ab3d13b76bba3c305ebbfc96f983cd6ca30c9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-05 | 169 | 211 | 7 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-05 | 169 | 211 | 7 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 10x5'-blood-Lymphocytic_Invariant-Inducer-like-MAIT|blood / Manually curated celltypes from each tissue | 2.05e-05 | 175 | 211 | 7 | b4e4b66e89f79999768a6192c8404cb2465f920b | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.05e-05 | 175 | 211 | 7 | 89bf89466191da14896ed8928027f5b911436c22 | |
| ToppCell | Ciliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.13e-05 | 176 | 211 | 7 | 1c364155f46b9a7c995bdc2cc2333c437cd90f5b | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 2.13e-05 | 176 | 211 | 7 | 7a74217b7fa1032b918f00a3972dff5fab74671a | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.13e-05 | 176 | 211 | 7 | 450c25ec5eeb65425f904e0a25aaafdf5682ef9c | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.21e-05 | 177 | 211 | 7 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-05 | 177 | 211 | 7 | 928118b0ed120ec01c7d753ce523ab609ac24e5f | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.29e-05 | 178 | 211 | 7 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 179 | 211 | 7 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.43e-05 | 121 | 211 | 6 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 181 | 211 | 7 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-05 | 181 | 211 | 7 | be4f35c9eb5b3083acb2264128f095fac1f3da45 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 2.64e-05 | 182 | 211 | 7 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.64e-05 | 182 | 211 | 7 | d7cce5dd7046f06bf40f00c9dbfa610722b03333 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-T_NK_proliferative|Bac-SEP / Disease, Lineage and Cell Type | 2.83e-05 | 184 | 211 | 7 | 848d05afd5a2ef61fb8a09c0f5fa2a56fd5c160b | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.93e-05 | 185 | 211 | 7 | fa94c4a1660967f211ba095606cd0aa37d38e17a | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 2.93e-05 | 185 | 211 | 7 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-DC1|Liver / Manually curated celltypes from each tissue | 3.03e-05 | 186 | 211 | 7 | e823529ffd06352c6bdec102f221fdf27f7c7369 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.13e-05 | 187 | 211 | 7 | 37d8ee5c8bd6324749e5a2adef1d0482c75da80c | |
| ToppCell | 3'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.13e-05 | 187 | 211 | 7 | ec98d5e480b08854dfd0ba6b1dc6610455f90640 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-05 | 187 | 211 | 7 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells-Tumor_ECs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.13e-05 | 187 | 211 | 7 | be5f8c5802b0fa8cc1e274fdf06b13eb8ceb8ad4 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.20e-05 | 127 | 211 | 6 | 9bc55cb9f4bddb274930784d12a83b9dceb35cb7 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-Cycling_NK|Liver / Manually curated celltypes from each tissue | 3.24e-05 | 188 | 211 | 7 | 5eb94e652a734c6f15c68a178e9d05f0febcf34c | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.24e-05 | 188 | 211 | 7 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 3.24e-05 | 188 | 211 | 7 | 723348a1836a074e068320cb736ce6a953e0038f | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.35e-05 | 189 | 211 | 7 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 3.35e-05 | 189 | 211 | 7 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 3.35e-05 | 189 | 211 | 7 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.35e-05 | 189 | 211 | 7 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-05 | 190 | 211 | 7 | 1803b1e7c36285f9eaabc3c6e9a9752c5908db3d | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.59e-05 | 191 | 211 | 7 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 3.59e-05 | 191 | 211 | 7 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.59e-05 | 191 | 211 | 7 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.59e-05 | 191 | 211 | 7 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | Dividing_Macrophages-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.71e-05 | 192 | 211 | 7 | 741bd0c2b0a7ce3fcb1610ce8bdacaf9a803c212 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.71e-05 | 192 | 211 | 7 | ed1fb700d3e8f00495727d61e164fc0b70274fd0 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.71e-05 | 192 | 211 | 7 | 6779b0294bb058e748e22b795b6a381c4add37e9 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.80e-05 | 131 | 211 | 6 | 96d300958545714d18e905e860e95469c8ae4efa | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.83e-05 | 193 | 211 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.83e-05 | 193 | 211 | 7 | 0373984547cefc0cbd77f8e795d508f6fcebc6c8 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.83e-05 | 193 | 211 | 7 | b835d28de9daeec5213172c96f62b332cda53bb5 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.96e-05 | 194 | 211 | 7 | e5b81a8e52259a54a911c1c2ac932c98c988318d | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 194 | 211 | 7 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.09e-05 | 195 | 211 | 7 | 67670d16ddd5d5ab7bc2254df329f5a7b2581556 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.09e-05 | 195 | 211 | 7 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.09e-05 | 195 | 211 | 7 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 4.09e-05 | 195 | 211 | 7 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.09e-05 | 195 | 211 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.09e-05 | 195 | 211 | 7 | 47a01b8a92eebeb34ac7f70bf1ab4613a326e24f | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.09e-05 | 195 | 211 | 7 | 23dc2f8a3a038195a31feee7e3a51094a7a7c23e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.23e-05 | 196 | 211 | 7 | 9d4f0a95e49bda25864cbe27e4e86096cba5609f | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-Plasmablast|Influenza_Severe / Disease, condition lineage and cell class | 4.37e-05 | 197 | 211 | 7 | 9108edafbf5744ed65f556bcbbf819a9b71176a9 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Large_pre-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.37e-05 | 197 | 211 | 7 | cebf47d66f425c84d3fea962e11f5bf4bfe2e60f | |
| ToppCell | (3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.37e-05 | 197 | 211 | 7 | 048bc4f8fd5d4f394e2384700640f72042336597 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Deuterosomal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.37e-05 | 197 | 211 | 7 | 861e8df9bd74dc5e17bafdc1fb3fef546753c73a | |
| ToppCell | severe-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.37e-05 | 197 | 211 | 7 | c8a90d82170cf20e14aebecddcf7cc0ca56cda87 | |
| ToppCell | 343B-Myeloid-Dendritic|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.37e-05 | 197 | 211 | 7 | b340d6f041231e5c69140895aaa1e8d28bafb998 | |
| ToppCell | distal-Hematologic-Proliferating_NK/T-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.37e-05 | 197 | 211 | 7 | 04b10879e48c101d1de449db0bc6b6484090b965 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 4.51e-05 | 198 | 211 | 7 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2) | 4.51e-05 | 198 | 211 | 7 | ed86b0247006befe55400c287d334d2202b470bd | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 4.51e-05 | 198 | 211 | 7 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | distal-2-Hematologic-Proliferating_NK/T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.51e-05 | 198 | 211 | 7 | a5fd710df5669c95fc5b5ef6e5cfafe6687c7b72 | |
| ToppCell | (3)_DC_Monocyte_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.51e-05 | 198 | 211 | 7 | e2b89f6d7c0007ccab62495cd543fe0e5513a9a4 | |
| ToppCell | MS-cycling-|MS / Condition, Cell_class and T cell subcluster | 4.51e-05 | 198 | 211 | 7 | 19c5d6b65de490118574b1f86b45c58b3a51df7f | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.51e-05 | 198 | 211 | 7 | 428182c71f009906c581e02257e545ea5fb99650 | |
| ToppCell | distal-1-Hematologic-Proliferating_Macrophage|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.51e-05 | 198 | 211 | 7 | df3f5559ecd1f3cd1fd60e39dbad8741309e83a3 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.51e-05 | 198 | 211 | 7 | 55ea8c9d2154ded74c7b851735b24c95bae01de4 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|World / disease group, cell group and cell class | 4.51e-05 | 198 | 211 | 7 | 48045689d0969ff0a14eee7086b8e19b0d6b6065 | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A_EA | SAMD9 TBC1D2B SLC7A11 UBR4 SMURF1 HIPK2 PCDHA5 CD3D PKP3 ADAM2 IL1R1 | 2.32e-06 | 197 | 210 | 11 | 1003_UP |
| Disease | Sotos' syndrome | 1.37e-06 | 4 | 208 | 3 | C0175695 | |
| Disease | Neurodevelopmental Disorders | 4.43e-06 | 93 | 208 | 7 | C1535926 | |
| Disease | LDL cholesterol change measurement | 1.18e-05 | 7 | 208 | 3 | EFO_0007804 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 4.62e-05 | 91 | 208 | 6 | EFO_0004611, EFO_0005271 | |
| Disease | hereditary elliptocytosis (is_marker_for) | 4.95e-05 | 2 | 208 | 2 | DOID:2373 (is_marker_for) | |
| Disease | mean reticulocyte volume | SAMD9 ZNF318 ARMC2 TBC1D16 PIK3R1 AFDN HSP90AB1 CAD NYAP2 GTPBP1 TERT SLC4A1 TIGD6 PPP2R1B ATF7IP EPB41 IPO11 | 5.69e-05 | 799 | 208 | 17 | EFO_0010701 |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 7.25e-05 | 12 | 208 | 3 | C0023485 | |
| Disease | Malignant neoplasm of breast | KDM3A APC2 ZNF318 CHEK1 DDX10 NHS DLEC1 NIPBL FOXM1 FN1 UBR4 NUP214 TERT RIF1 SETD2 PPARGC1B PAEP ITSN2 APPL1 CPSF3 | 7.99e-05 | 1074 | 208 | 20 | C0006142 |
| Disease | cholesterol in very large VLDL measurement | 9.72e-05 | 65 | 208 | 5 | EFO_0022230 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 1.29e-04 | 69 | 208 | 5 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | neogenin measurement | 1.48e-04 | 3 | 208 | 2 | EFO_0801823 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 2.39e-04 | 43 | 208 | 4 | EFO_0022290 | |
| Disease | lean mass-adjusted fat body mass | 2.61e-04 | 18 | 208 | 3 | EFO_0009890 | |
| Disease | Elliptocytosis found | 2.94e-04 | 4 | 208 | 2 | C0427480 | |
| Disease | Hereditary elliptocytosis | 2.94e-04 | 4 | 208 | 2 | cv:C0013902 | |
| Disease | autosomal recessive congenital ichthyosis 4B (implicated_via_orthology) | 2.94e-04 | 4 | 208 | 2 | DOID:0060713 (implicated_via_orthology) | |
| Disease | hydrocephalus (implicated_via_orthology) | 3.08e-04 | 19 | 208 | 3 | DOID:10908 (implicated_via_orthology) | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 3.08e-04 | 19 | 208 | 3 | EFO_0802076 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 3.26e-04 | 84 | 208 | 5 | DOID:9119 (is_implicated_in) | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 4.63e-04 | 51 | 208 | 4 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | white matter microstructure measurement | PLEKHM1 EFTUD2 NYAP2 DOCK9 BRSK2 APOB SRGAP2 GTPBP1 WDFY3 CDC5L | 4.81e-04 | 390 | 208 | 10 | EFO_0005674 |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 4.82e-04 | 22 | 208 | 3 | EFO_0009312 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 6.61e-04 | 56 | 208 | 4 | EFO_0022279 | |
| Disease | Adenoid Cystic Carcinoma | 7.26e-04 | 100 | 208 | 5 | C0010606 | |
| Disease | Elliptocytosis, Hereditary | 7.28e-04 | 6 | 208 | 2 | C0013902 | |
| Disease | monocyte percentage of leukocytes | RPN1 CHMP7 MCM3AP ULK4 NYAP2 MEI1 TERT SNX29 SETD2 ITSN2 SCUBE3 WDFY3 CDC5L MUSK | 7.33e-04 | 731 | 208 | 14 | EFO_0007989 |
| Disease | total lipids in VLDL measurement | 8.59e-04 | 60 | 208 | 4 | EFO_0022314 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 8.59e-04 | 60 | 208 | 4 | EFO_0022282 | |
| Disease | sexual dimorphism measurement | ARMC2 STX4 CEP120 PIK3R1 ULK4 MGA GCN1 FOXM1 NYAP2 NSD1 APOB PKD1L3 CERT1 SLC4A1 AVIL SCUBE3 MAPKBP1 PC | 8.95e-04 | 1106 | 208 | 18 | EFO_0021796 |
| Disease | triglycerides in medium LDL measurement | 9.72e-04 | 62 | 208 | 4 | EFO_0022322 | |
| Disease | free cholesterol in very large HDL measurement | 9.72e-04 | 62 | 208 | 4 | EFO_0022273 | |
| Disease | Urogenital Abnormalities | 1.01e-03 | 7 | 208 | 2 | C0042063 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 1.03e-03 | 108 | 208 | 5 | DOID:684 (biomarker_via_orthology) | |
| Disease | triglycerides to total lipids in IDL percentage | 1.03e-03 | 63 | 208 | 4 | EFO_0022329 | |
| Disease | cholesterol in large VLDL measurement | 1.16e-03 | 65 | 208 | 4 | EFO_0021902 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 1.23e-03 | 66 | 208 | 4 | EFO_0003940, EFO_0004611 | |
| Disease | total lipids in very large HDL measurement | 1.23e-03 | 66 | 208 | 4 | EFO_0022312 | |
| Disease | total lipids in large VLDL | 1.30e-03 | 67 | 208 | 4 | EFO_0022175 | |
| Disease | Alcohol abuse | 1.30e-03 | 67 | 208 | 4 | C0085762 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 1.30e-03 | 67 | 208 | 4 | EFO_0022245 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 1.35e-03 | 8 | 208 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | Hereditary spherocytosis | 1.35e-03 | 8 | 208 | 2 | C0037889 | |
| Disease | fat body mass, lean body mass | 1.35e-03 | 8 | 208 | 2 | EFO_0004995, EFO_0005409 | |
| Disease | microcephaly (is_implicated_in) | 1.35e-03 | 8 | 208 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | antihyperlipidemic drug use measurement | 1.36e-03 | 115 | 208 | 5 | EFO_0803367 | |
| Disease | free cholesterol in large VLDL measurement | 1.37e-03 | 68 | 208 | 4 | EFO_0022265 | |
| Disease | cortical surface area measurement | MON2 EFCAB5 SAMD9 SREBF1 PLEKHM1 TBC1D16 CHMP7 NEO1 CEP120 PIK3R1 NYAP2 DOCK9 BRSK2 HIPK2 CERT1 DNAH7 MDC1 FSHR CDC5L PC | 1.40e-03 | 1345 | 208 | 20 | EFO_0010736 |
| Disease | triglycerides to total lipids in very small VLDL percentage | 1.45e-03 | 69 | 208 | 4 | EFO_0022341 | |
| Disease | cholesterol in very large HDL measurement | 1.45e-03 | 69 | 208 | 4 | EFO_0022229 | |
| Disease | idiopathic pulmonary fibrosis (is_implicated_in) | 1.72e-03 | 9 | 208 | 2 | DOID:0050156 (is_implicated_in) | |
| Disease | non-high density lipoprotein cholesterol measurement | GC STX4 NYAP2 FN1 NSD1 APOB CERT1 DENND4C RBCK1 CELSR2 ITSN2 HYDIN MUSK | 1.74e-03 | 713 | 208 | 13 | EFO_0005689 |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 1.75e-03 | 312 | 208 | 8 | EFO_0004612, EFO_0010351 | |
| Disease | Testicular Germ Cell Tumor | 1.79e-03 | 73 | 208 | 4 | EFO_1000566 | |
| Disease | leucine measurement | 1.79e-03 | 73 | 208 | 4 | EFO_0009770 | |
| Disease | osteoarthritis (is_marker_for) | 1.91e-03 | 35 | 208 | 3 | DOID:8398 (is_marker_for) | |
| Disease | coronary artery disease | SREBF1 CEP120 SHOC1 DLEC1 NYAP2 FN1 DSCAM DOCK9 RNF213 APOB ANKRD50 PKD1L3 CERT1 RSBN1 PPP2R1B CD3D CELSR2 GABBR1 | 2.09e-03 | 1194 | 208 | 18 | EFO_0001645 |
| Disease | Uterine leiomyoma, estrogen-receptor negative breast cancer | 2.14e-03 | 10 | 208 | 2 | EFO_1000650, HP_0000131 | |
| Disease | Self-injurious behavior | 2.28e-03 | 78 | 208 | 4 | HP_0100716 | |
| Disease | HMG CoA reductase inhibitor use measurement | 2.29e-03 | 189 | 208 | 6 | EFO_0009932 | |
| Disease | cortical thickness | MON2 A2M SREBF1 ZNF318 VIT PLEKHM1 CHMP7 NEO1 CEP120 PIK3R1 DLEC1 NYAP2 DOCK9 SRGAP2 FSHR CDC5L MUSK | 2.42e-03 | 1113 | 208 | 17 | EFO_0004840 |
| Disease | gastrointestinal stromal tumor (is_implicated_in) | 2.61e-03 | 11 | 208 | 2 | DOID:9253 (is_implicated_in) | |
| Disease | beta thalassemia (is_marker_for) | 2.61e-03 | 11 | 208 | 2 | DOID:12241 (is_marker_for) | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 2.81e-03 | 40 | 208 | 3 | EFO_0004746 | |
| Disease | testicular carcinoma | 2.81e-03 | 40 | 208 | 3 | EFO_0005088 | |
| Disease | valine measurement | 2.81e-03 | 40 | 208 | 3 | EFO_0009792 | |
| Disease | diabetes mellitus (is_marker_for) | 3.02e-03 | 41 | 208 | 3 | DOID:9351 (is_marker_for) | |
| Disease | cancer (implicated_via_orthology) | 3.03e-03 | 268 | 208 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | metabolic syndrome | 3.04e-03 | 200 | 208 | 6 | EFO_0000195 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 3.25e-03 | 86 | 208 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | free cholesterol to total lipids in IDL percentage | 3.46e-03 | 43 | 208 | 3 | EFO_0022278 | |
| Disease | fatty acid measurement, fetal genotype effect measurement, breast milk measurement | 3.66e-03 | 13 | 208 | 2 | EFO_0005110, EFO_0007959, EFO_0009092 | |
| Disease | iron deficiency anemia (biomarker_via_orthology) | 3.66e-03 | 13 | 208 | 2 | DOID:11758 (biomarker_via_orthology) | |
| Disease | concentration of large LDL particles measurement | 3.70e-03 | 44 | 208 | 3 | EFO_0022160 | |
| Disease | cholesterol in medium VLDL measurement | 3.70e-03 | 44 | 208 | 3 | EFO_0022225 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 3.94e-03 | 45 | 208 | 3 | EFO_0022236 | |
| Disease | triacylglycerol 54:4 measurement | 4.19e-03 | 46 | 208 | 3 | EFO_0010422 | |
| Disease | fatty acid measurement, breast milk measurement, parental genotype effect measurement | 4.26e-03 | 14 | 208 | 2 | EFO_0005110, EFO_0005939, EFO_0009092 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 4.26e-03 | 14 | 208 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | total lipids in small LDL | 4.46e-03 | 47 | 208 | 3 | EFO_0022168 | |
| Disease | free cholesterol in small VLDL measurement | 4.46e-03 | 47 | 208 | 3 | EFO_0022272 | |
| Disease | free cholesterol in medium VLDL measurement | 4.46e-03 | 47 | 208 | 3 | EFO_0022269 | |
| Disease | Prostatic Neoplasms | PRSS8 SAMD9 DHDH PIK3R1 MGA HSP90AB1 TERT SETD2 PKP3 ITSN2 NCOA7 | 4.53e-03 | 616 | 208 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | PRSS8 SAMD9 DHDH PIK3R1 MGA HSP90AB1 TERT SETD2 PKP3 ITSN2 NCOA7 | 4.53e-03 | 616 | 208 | 11 | C0376358 |
| Disease | pulse pressure measurement | ZNF318 AKR1A1 SRCAP CEP68 CEP120 ULK4 DLEC1 NYAP2 FN1 DSCAM RNF213 PCDHA5 MEI1 PKD1L3 DENND4C CD3D COASY HYDIN MUSK | 4.68e-03 | 1392 | 208 | 19 | EFO_0005763 |
| Disease | total blood protein measurement | 4.79e-03 | 449 | 208 | 9 | EFO_0004536 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 4.83e-03 | 220 | 208 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | African Burkitt's lymphoma | 4.89e-03 | 15 | 208 | 2 | C0343640 | |
| Disease | diffuse idiopathic skeletal hyperostosis | 4.89e-03 | 15 | 208 | 2 | EFO_0007236 | |
| Disease | lysophosphatidylcholine 14:0 measurement | 4.89e-03 | 15 | 208 | 2 | EFO_0010356 | |
| Disease | Hypertriglyceridemia | 4.89e-03 | 15 | 208 | 2 | C0020557 | |
| Disease | response to statin, LDL cholesterol change measurement | 4.89e-03 | 15 | 208 | 2 | EFO_0007804, GO_0036273 | |
| Disease | unipolar depression, cognitive function measurement | 4.89e-03 | 15 | 208 | 2 | EFO_0003761, EFO_0008354 | |
| Disease | Burkitt Leukemia | 4.89e-03 | 15 | 208 | 2 | C4721444 | |
| Disease | phospholipids in medium LDL measurement | 5.01e-03 | 49 | 208 | 3 | EFO_0022183 | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 5.01e-03 | 49 | 208 | 3 | EFO_0021897 | |
| Disease | cholesterol in medium LDL measurement | 5.01e-03 | 49 | 208 | 3 | EFO_0022224 | |
| Disease | cholesterol in small LDL measurement | 5.01e-03 | 49 | 208 | 3 | EFO_0022227 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 5.26e-03 | 224 | 208 | 6 | EFO_0004530, EFO_0008317 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 5.26e-03 | 224 | 208 | 6 | EFO_0004574, EFO_0008317 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 5.30e-03 | 50 | 208 | 3 | EFO_0022334 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NKLVPISEVSLDPII | 101 | A8MVM7 | |
| LLPPLENLATVEETV | 101 | P30154 | |
| ELAQPLRKEPEIITV | 996 | P55196 | |
| SLDEEIILKAPIAAP | 121 | P11171 | |
| ESEPLNITVIKAPRE | 186 | P12319 | |
| LSQVSPFKIPIEELE | 16 | P04234 | |
| SIIKPTVPDEIIDQK | 231 | O75366 | |
| VEPPLTDLQKSEELI | 561 | Q99459 | |
| EEKTNPLSELPIELE | 201 | Q8NFR7 | |
| LAKVSSSLEPVVPQE | 221 | Q76N32 | |
| LVENPSARITIPDIK | 246 | O14757 | |
| VPEKPILSELTFLEV | 866 | Q68DQ2 | |
| AEIPNIKPDILIIES | 191 | Q9UKF6 | |
| ILEKIPPDSEATLVL | 216 | P02730 | |
| DVILDPKTANPILLV | 341 | O00481 | |
| DSLPVQITVPEKIRS | 21 | Q99965 | |
| IVQILATDPTKPLDV | 831 | Q9UNA0 | |
| NSTTEKIEPRELDPI | 341 | Q9H9E3 | |
| EKPNDPTLELISETL | 2126 | Q86UK0 | |
| QTIETHPIPESLIEK | 266 | Q7Z5W3 | |
| PPSEAEDVLIKLTRV | 596 | Q8NEN0 | |
| QKLPSPLDITAERVE | 361 | Q7Z2Z2 | |
| EPELDLTSKLVLVSP | 56 | O00178 | |
| ALAPKEDPVLTVITQ | 181 | Q86SQ3 | |
| PPATEKLTTAQEVLA | 351 | Q9H211 | |
| IETPTNPTQKVIDIE | 156 | P32929 | |
| PVRDSLSTLIPKEQE | 481 | Q9ULJ7 | |
| QEVASLPDVPADLLK | 406 | Q12797 | |
| EELLPRALDKPVTVQ | 2291 | Q9HCU4 | |
| VKPVTESEQPTVLEL | 46 | Q96M86 | |
| NDTVILDPPLVALDK | 56 | Q9H4D0 | |
| EVSEELSLKLPPNVV | 926 | P01023 | |
| PSPLVKQLSEVFETE | 86 | Q99618 | |
| IESAKLLPDTPVQFI | 971 | Q6ZP01 | |
| DENSLISTKEEPPVL | 1331 | Q96L73 | |
| VSPRPALESEELLVK | 1381 | Q96L73 | |
| TPIFLNEVLVKLPTD | 1491 | Q9NZM3 | |
| ELDLPILKVAAPEIV | 321 | O15381 | |
| PEPELIDSTKLIEVQ | 36 | P49146 | |
| LTPVSTENEIKLDPS | 121 | Q86WS3 | |
| QIDKILDPTASVPSV | 1571 | Q9HCM3 | |
| VIRKIPALTENDPET | 511 | Q9Y5P4 | |
| RDPVNPEKLLVITVA | 31 | O60568 | |
| ITSLLPTPEDNLEIV | 61 | P09466 | |
| LKIDIIPNPQERTLT | 71 | P08238 | |
| VLEPLVNLLTAPDVK | 411 | A9QM74 | |
| TIIVPPLKTQASEVL | 966 | Q9H2X6 | |
| VKTPETVVPTALELQ | 1196 | Q14676 | |
| KSLLAPLNVELDPEI | 111 | Q86Y46 | |
| VVAVSPDLLESDLKP | 2616 | Q8IWI9 | |
| LAEPASEPDVLKIVI | 2916 | Q8IWI9 | |
| TPSLLEQEVKPSTEL | 486 | P14672 | |
| PKEDIDVSILPQLEH | 746 | Q9UBS5 | |
| LSVQLKPEVSPTQDI | 41 | Q9BYM8 | |
| PELIPTLIESVKVQD | 126 | Q9UI26 | |
| KLPIEETLEDSPQTR | 6 | Q9UKG1 | |
| KLVLVLPDVEEQSPE | 1361 | O60318 | |
| KVQIRSLPSLEDIDP | 286 | Q8IWQ3 | |
| NLSEEESPIKIVPHV | 6511 | Q5CZC0 | |
| INPSLSADVPKVEVL | 211 | Q9NVF9 | |
| DIIKIIDPSAQISPT | 211 | Q6PEV8 | |
| DVIILEENSTPKPAV | 576 | Q14149 | |
| VILATRTPPKEEQSE | 41 | Q5SWX8 | |
| DSVRLKVQPIPELSE | 301 | Q92614 | |
| IIRQPSEEEIIKLAP | 111 | Q15121 | |
| SVLKELPPELLAEIE | 1046 | Q6KC79 | |
| IPLTPVEIQDLELAT | 186 | Q6UWB1 | |
| PLKTLEEEDQSIVRP | 721 | P48681 | |
| NQVEITISDEKTLPP | 371 | P35658 | |
| LPSPEAEAIELAVVK | 111 | Q6X4W1 | |
| LPNIVPKLTEVLTDS | 1536 | Q92616 | |
| LPTNLPVDTVKLRIE | 51 | Q3SXY7 | |
| EKAPANPEILLTLEE | 251 | O15553 | |
| EILQIVSPVRDSDKP | 1171 | Q7Z3U7 | |
| TPLEVTKLPVLENVS | 356 | Q9P242 | |
| LPVKEDAPLSTVIAL | 356 | Q9Y5H7 | |
| DIAPPLLIKLVEAIE | 126 | P27986 | |
| PLVVQLAKTEAESPR | 311 | Q9HC73 | |
| IPTDLVPVNLLLEVK | 41 | Q86Y13 | |
| PSEALLVDIKLEPLA | 621 | Q9NYZ3 | |
| LVDIKLEPLAVTPDA | 626 | Q9NYZ3 | |
| VIDEAAAIPLPLVKS | 386 | Q9H0A0 | |
| VPAPSIRKQILEELE | 356 | Q6ZV29 | |
| SPSIKLLVDDPIVVN | 241 | Q7Z553 | |
| PPSKEELSAVSELLQ | 646 | Q5TIA1 | |
| LTIPNLEQIEKPISI | 321 | Q9UJ42 | |
| PLSEEQLIDIKVAHP | 46 | Q9UMS4 | |
| KELHETLQSVPDVPV | 31 | A4FU69 | |
| ISALLVPPETEEAKQ | 161 | P04114 | |
| TEPQALLAVKSVPVD | 236 | O95996 | |
| ILFTIPELQEPKVLT | 4456 | Q4G0P3 | |
| TVPITPDNVEKLLAA | 101 | Q6JEL2 | |
| EEIPALKIVDPSLIH | 226 | Q9Y4C1 | |
| VKDESLALPAVNPLV | 1196 | Q9BZ29 | |
| TTPIAELLIVAPEKL | 216 | Q9BWC9 | |
| TVSPVLVPKDQLLSE | 576 | Q5THR3 | |
| IQISIALETDTKPPV | 126 | Q8N960 | |
| ERDAPIVNKVVTPLS | 1161 | P02751 | |
| ILLQDTTKEPLDLPD | 386 | Q8WUX9 | |
| PLDAEDKLPVLTVVD | 46 | Q8TAL5 | |
| KPTTLKPIILNEIVD | 456 | Q8WXX0 | |
| EELDPILEPLLLKQT | 3041 | Q8WXX0 | |
| KTIQDLPEVLLPALE | 521 | Q86WZ0 | |
| KITLLELEDVPLQPQ | 601 | Q6UWU2 | |
| QELLEPVVDDVPKTT | 1136 | Q5VZ89 | |
| TSLEAEVPPDLALNK | 41 | A2IDD5 | |
| LSEAKPATPEIQEIV | 6 | P01040 | |
| IPILEKLAPSEDELT | 436 | Q6VMQ6 | |
| QLQPLESKPSLVEVE | 306 | P20794 | |
| TEEELPALPVLAKST | 796 | O60336 | |
| KESPVIPLSESELLA | 301 | Q9UQ10 | |
| SPLLPVQTIKEEEIQ | 451 | Q08050 | |
| LPIPSQNLTDELVKI | 1511 | A4D0S4 | |
| LESEEILVAPEALPK | 731 | Q86VF2 | |
| IPTNFEILPLEKEAT | 531 | P14735 | |
| PPLDEILSKVTEVSN | 246 | Q9NT22 | |
| KVIEPRAPSLTNDEV | 531 | Q13206 | |
| PLIIEEKQIPASTTF | 2246 | A6NE01 | |
| KVTEIPSDLPRNAIE | 36 | P23945 | |
| PEQKLATPELLETAQ | 656 | Q8N6R0 | |
| SEKVRLEILPVPQSQ | 321 | Q9C0E4 | |
| PLLETISKENESPEI | 216 | Q6P6B1 | |
| VTPEVLDRSQLVEKP | 266 | Q6P6B1 | |
| ILPETLPLTKTEEQI | 136 | O43889 | |
| VQDLESLVRLPPVKS | 176 | Q9Y238 | |
| KLQPPAVLTLEDTDV | 146 | Q9BRL7 | |
| KILIVVPEIFLPSED | 841 | Q8IX30 | |
| DPPIILQEQKTVLAS | 311 | Q96ER3 | |
| ITLEENKPTRPVIVS | 216 | P14778 | |
| VNLIEVSLSDLKPPE | 1121 | Q08AD1 | |
| EVPLATLEPLVKAQL | 261 | Q99574 | |
| KVEALEPEVSLPAAL | 51 | Q9BTL4 | |
| QEITLPPSRKSELVV | 596 | P43121 | |
| NSSEIITVEPLAKAP | 1271 | O60469 | |
| STIPPLIKSVVQNEE | 1571 | O60469 | |
| SAQVPEPDAIKESLL | 676 | Q9Y4G2 | |
| PIPVLKVESRLDSDQ | 776 | Q5VWQ0 | |
| NPKLTVIVPDDDRSL | 251 | Q9NWD8 | |
| KNSEPEEVIPSRLDI | 356 | P54577 | |
| VSLPEQPKVTITEAI | 456 | Q17RP2 | |
| EVIASKAPLETPTQL | 196 | Q7Z736 | |
| ALPTIPERKEVLLEA | 501 | O94763 | |
| AVSILIKPEQETDPL | 226 | Q8TEQ0 | |
| DPILKDDPTVITQDL | 106 | Q5TGY1 | |
| PIQKEVADSLASLPE | 891 | A6NFQ2 | |
| RVLSTLDPKQEAVPV | 176 | Q6T4R5 | |
| RIQVPIEDILPSKEE | 636 | Q8NI08 | |
| TKVLKPVVELLSNPD | 136 | Q9H3E2 | |
| SDIIDPVALEIPLSK | 2401 | Q5UIP0 | |
| PEKSARIPDSIAVIQ | 841 | Q5K651 | |
| ELKVLPDPEVISDLV | 236 | Q92859 | |
| LEKSLIVSIDPDSPL | 541 | Q7Z443 | |
| PAPEVDELSLLQKLL | 146 | Q86YN6 | |
| SEAPPLINEDVKRTV | 26 | P04843 | |
| SLSELKELLNPVPEI | 196 | Q5VXU9 | |
| IPTEKLLSQLPEVHE | 281 | Q96M53 | |
| FVEVKDLLTLVPPLV | 96 | Q96GZ6 | |
| AILDISKTILPAPVE | 486 | Q5T8A7 | |
| VQLVDLASTEKPPVD | 166 | Q5MNZ6 | |
| PDLPNITIDKTLTED | 1336 | P14410 | |
| LDVVSPIPANKDLSE | 761 | Q13017 | |
| ELEKQQVTILATPLP | 61 | Q12846 | |
| VLEETRKETAPVQLP | 571 | Q9BVR0 | |
| KPLQQLEVPLISRET | 186 | Q16651 | |
| LPVAVEILPVSEKNL | 2586 | Q6ZRS2 | |
| EDLRTKLTVIPQDPV | 1191 | Q96J65 | |
| KPIQLSDLESVDPEL | 521 | Q9HCE7 | |
| FDIPPQEILTKDSVT | 101 | P27105 | |
| QLLPEVIIDKPATDD | 666 | P35498 | |
| LATVPLVVDAEKLPI | 291 | P36956 | |
| LPSVEVDVEAPRAKL | 2941 | Q8IVF2 | |
| PVLLEEPVVLALAEK | 226 | P14550 | |
| PEVEVRSSKELLLQP | 36 | P59998 | |
| VDIKPSLTFDVIPLL | 256 | Q13057 | |
| KSPPAEVLVNIIAVL | 711 | Q9Y446 | |
| NAPPEKEVIESLLSL | 4081 | Q63HN8 | |
| TEEVENPEKTIPLAI | 256 | Q9UPY5 | |
| TVPPSLESRVENKEL | 191 | Q53GI3 | |
| KLTQVPDDLPTNITV | 41 | O15455 | |
| IPSLFEIVVKPTVDL | 426 | P61129 | |
| TDLSPKPLISEQTVI | 131 | P15622 | |
| KQTPLIDLLLEASPE | 1981 | Q8IZQ1 | |
| AEVAPQPLKESAVLT | 191 | P17040 | |
| DIVDILKNSAVLPPT | 176 | Q9ULR3 | |
| PITLPIEEVLQTLQD | 431 | Q15413 | |
| VKHTPDVVLDTLEPL | 966 | O75044 | |
| RPTLTPKDEDILVVA | 131 | Q8TBP0 | |
| ESKPSEELLEGQPVL | 561 | P35916 | |
| ARLVKLAQEDTPPET | 786 | Q9UHP3 | |
| QKVPTADLEDVLPLA | 241 | P02774 | |
| LQLVTDPPQLTVKDI | 1546 | Q9HCK1 | |
| PKEELSTQSLEPVSL | 271 | Q6UXI7 | |
| SLDEQVIPARLPKTE | 61 | A8MX80 | |
| TLELANKPLPVDDIL | 1456 | Q92576 | |
| KISLHPIEDNPIEEI | 1041 | Q9NTJ3 | |
| AASQISEVKPVLPEL | 951 | Q9Y4E1 | |
| LIKTVDIEEADPPQL | 571 | Q9H0V1 | |
| TLVTPPQDITAKTLE | 1166 | P27708 | |
| LQEEIIKTLEHLPIP | 1796 | Q9BYW2 | |
| KDLVVLELATPPLTQ | 261 | O15195 | |
| APPLEKILSVDSVAV | 681 | A8K0R7 | |
| SLDDQVIPARLPKTE | 61 | Q8N9G6 | |
| PVSEDPVAIKIAELL | 386 | Q14694 | |
| TQEVQELPIPSKLLE | 401 | Q9Y6I7 | |
| ETELTSPILLPDLQI | 761 | Q9BXT5 | |
| ETAVPSVLKPDLIDV | 606 | Q96QU8 | |
| SVIKIAVEPVNPSEL | 586 | Q15029 | |
| EVKIDLPLPIVASNL | 3626 | Q5T4S7 | |
| IAKETLPDLVSIIPD | 766 | Q99959 | |
| SLPPLDLQALEKELV | 981 | P11498 | |
| LLDPTPKDLEESIVQ | 256 | Q9UPU7 | |
| VVKESSADLLLPPDI | 1391 | Q5VUA4 | |
| EPVKEVRVSATLPDL | 226 | Q96G27 | |
| LPELPKTTALELQES | 361 | P18583 | |
| EPLPVKESDQTLAAL | 1681 | P18583 | |
| PQDRLTEVIASIIKP | 721 | O14746 | |
| VLDPVVEEKIQSIPL | 456 | Q6ZSZ6 | |
| TLNIERPEPSLKIVE | 381 | A8MT70 | |
| DSDLVVTPIIDNPKI | 416 | Q96C45 | |
| LVLESPAPVEVNLKL | 291 | Q9BWF2 | |
| KAPVITTPLETVDAL | 26 | O15146 |